Private Flu Vaccine Shortage Returns as Manufacturing Delays Cancel Appointments
Private flu vaccine appointments across Dublin and beyond are being cancelled again over the next two weeks, with pharmacies and workplace providers blaming renewed manufacturing delays, The Irish Times reported.
The disruption is the second this season and comes as influenza activity in Ireland begins to climb from baseline-low levels.
- Private supply hit twice: Companies and private patients faced cancelled clinics at the end of September, and appointments for the next fortnight are now being wiped again.
- Free HSE vaccine unaffected: Supplies remain prioritised for older people, the immunocompromised and other at-risk groups on the free public schedule.
- Formulation change blamed: A Government source said manufacturers, for the first time in years, had to change the vaccine’s chemical composition to better match circulating strains.
Second wave of cancellations lands mid-November
McCabes pharmacy in Clarehall, north Dublin, told affected patients by email that no private stock exists at present. The pharmacy said appointments were deleted and refunds issued.
“Unfortunately due to manufacturing delays, no private batches of the flu vaccine are available at the moment,” the email said.
The same message confirmed that appointments for the HSE’s at-risk flu vaccines and Covid-19 vaccines remain available according to schedule. Medmark, which runs workplace flu vaccination programmes, also cancelled clinics, citing what it described as an unexpected disruption to the national influenza vaccine supply.
“We apologise for the inconvenience this may have caused, we confirm that the HSE (at risk) flu vaccines and Covid vaccines appointments are regularly available according to schedule,” the McCabes email said.
Medmark said the situation was outside its control and apologised for the inconvenience and disappointment.

September’s industry-wide failure set the pattern
The current cancellations repeat a disruption that began at the end of September, when companies across the State scrapped workplace flu clinics because they could not secure enough doses. At that point, available vaccines were being directed to the free HSE schedule for vulnerable groups, and many pharmacies stopped offering the jab to private patients.
Firms running workplace vaccination programmes said at the time that the private market was experiencing an unprecedented shortage of flu vaccine across the whole sector, brought on by a significant manufacturing breakdown. In the weeks after, many companies found sufficient supplies, clinics were reorganised, and private patients could buy the vaccine again.
Why the formulation changed this year
A Government source attributed this year’s private-market disruption to manufacturers having, for the first time in years, to change the chemical formulation of the jab so it targets specific strains better.
Strain-matching is the central variable in influenza vaccine production: each season’s vaccine is composed months in advance against the strains scientists expect to circulate, and any manufacturing adjustment ripples downstream through the supply chain. According to The Irish Times, the HSE’s free vaccination system, which gives priority to older people and the immunocompromised, is not impacted by the supply problems.
That prioritisation reflects clinical consensus on who carries the greatest risk. Influenza morbidity and mortality concentrate among older adults, pregnant women and people with weakened immune systems, which is why the World Health Organization and national agencies rank these groups first in seasonal immunisation programmes.
Irish patients seeking a private dose while stocks are constrained can check with their GP or local pharmacy about availability of the free at-risk schedule if they qualify, and employers arranging workplace clinics may want to confirm supply directly with occupational health providers before rebooking.
Virus levels are low, but rising
The latest data from the Health Protection Surveillance Centre, for the week ending November 8, show influenza activity has increased but remains at baseline-low levels. That week, 181 influenza cases were notified, along with 84 emergency department cases who were not hospitalised and 57 hospitalisations. Nine intensive care admissions and three deaths have been reported for the season to date.
Respiratory syncytial virus activity increased slightly but stayed at baseline-low levels, while Covid-19 activity stabilised at low-moderate levels. Over recent weeks, the number of hospital beds occupied by influenza patients has stayed low and steady, though the last fortnight saw a modest rise.
RSV cases have been highest in children under one. In the week ending November 8, that age group accounted for 27 cases, 17 non-hospitalised emergency department cases and six hospitalisations, according to the surveillance centre’s data.
What private patients face next
The cancellations run over the next two weeks, meaning private patients and employers will be watching whether manufacturers restore private batches before influenza activity builds further. The timing matters: vaccination is most useful before peak transmission, and Ireland’s respiratory season typically intensifies through December and January.
For now, the free HSE schedule continues as planned, and the surveillance data give no sign of an early surge. The three deaths and nine intensive care admissions recorded this season to date, per the Health Protection Surveillance Centre, remain the clearest measure of what the vaccine programme is working to prevent.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.